To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.

Institute of Liver and Biliary Sciences, India

Status: Not yet enrolling

Conditions: Chronic Liver Disease

Treatments: Other: No Intervention

Study type: Observational

Funder types: Other

Identifiers

NCT07270809

ILBS-CLD-66

Details and patient eligibility

About

Title - To study the clinical course and outcomes of non-electively hospitalised patients of chronic liver disease (CLD) with Hepatic or Extra-hepatic predominant organ failure(s) at 6 months.

Summary - ACLF is a condition where acute insult leading to worsening liver failure with or without extra-hepatic failure leads to a high short-term mortality. However, the presence of cirrhosis, prior decompensation, non-hepatic/systemic acute insult, organ failure and treatment are different in different part of the world. This is due to in-homogenous patient cohort. The current study was planned for all patients of CLD, who were non-electively hospitalized and were followed up for long-term to identify the differences in clinical course, acute insult, organ failure, therapy and outcome in relation to liver failure with or without extra-hepatic organic failure. In the study the laboratory, clinical parameters, inflammatory and regenerative markers will be evaluated as a marker of disease progression, reversal, recompensation or regression. This will enable us to differentiate the ACLF between east and west, guide us for defining the natural course of CLD with failure.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18-70 years
2. CLD with or without cirrhosis with 1st or subsequent admissions for decompenasation and irrespective of any prior decompensation
3. Non-electively hospitalized

Exclusion criteria

1. HCC
2. NCPF/EHPVO
3. Pregnancy
4. Post-Liver transplant

Trial design

100 participants in 2 patient groups

Chronic Liver Disease (CLD) With Hepatic Predominant Organ Failure

Treatment:

Other: No Intervention

Chronic Liver Disease (CLD) With Extra-hepatic Predominant Organ Failure

Treatment:

Other: No Intervention